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Abstract
Background:  Home-based management of fever (HBMF) could improve prompt access to
antimalarial medicines for African children. However, the perception of treatment failure by
caregivers has not been assessed.
Methods: Caregiver's perceived treatment outcome in HBMF and in alternative sources of fever
treatment was assessed in a rural Ugandan setting using nine hundred and seventy eight (978)
caregivers of children between two and 59 months of age, who had reported fever within two
weeks prior to the study.
Results: Lower caregivers' perceived treatment failure (15% and 23%) was observed in the formal
health facilities and in HBMF, compared to private clinics (38%), drug shops (55%) or among those
who used herbs (56%). Under HBMF, starting treatment within 24 hours of symptoms onset and
taking treatment for the recommended three days duration was associated with a lower perceived
treatment failure. Conversely, vomiting, convulsions and any illness in the month prior to the fever
episode was associated with a higher perceived treatment failure.
Conclusion:  In this medium malaria transmission setting, caregiver's perceived treatment
outcome was better in HBMF compared to alternative informal sources of treatment.
Background
Malaria is one of the leading causes of ill health and
deaths in Uganda, accounting for 46% of the illness in
children, 20–40% of out-patient visit at health facilities,
25% of hospital admissions, 14% of in-patient deaths and
20–23% of – infant and childhood mortality (Uganda
Ministry of Health,, surveillance reports, 2001). High
malaria transmission intensity, limited access to adequate
treatment, increasing parasite resistance to affordable and
safe medicines (chloroquine, sulphadoxine-pyrimeth-
amine and amodiaquine);, delayed seeking of care and
inappropriate treatment at home or within communities,
are some of the causes for this pervasive situation. Based
on the observation that the majority of fevers in Africa are
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due to malaria [1], and evidence demonstrating that
home management of malaria (HMM) reduces childhood
morbidity and mortality [2-4], some countries have
adopted the World Health Organization home-based
management of fever (HBMF) strategy in an effort to
improve prompt access to treatment. In Uganda, village
volunteers, called community drug distributors (CDD)
provide free pre-packaged antimalarial medicines
(HOMAPAK) to caregivers of febrile children. Caregivers
visit the CDD when they have a sick child and seek further
treatment in case of perceived treatment failure. The
HBMF strategy has enabled over 52% of the febrile chil-
dren in target areas to access treatment within 24 hours of
fever onset, and data from CDDs demonstrate a high
recovery (79% – 99%) [5]. Despite such a high recovery,
the out-patient department (OPD) attendance at health
facilities in the districts implementing HBMF has
increased since the inception of HBMF, yet a decline had
been anticipated. Several factors could be responsible
including (i) increased availability of drugs (fewer stock-
outs) resulting in increased overall health facility contacts
per person per year, (ii) increased access to health services
through the opening up of new health centres; (iii) HBMF
serving the hard-to-reach population, that previously
never attended formal health care, consequently there is
little or no effect on OPD attendance; (iv) surveillance
bias due to improved completeness of reporting, and
finally (v) increased parasite resistance to chloroquine
(CQ) + sulphadoxine-pyrimethamine (SP), the present
regimen in HBMF. Indeed, the high parasite resistance to
CQ + SP has led to concerns that the effectiveness of
HBMF was very low, [6-10], probably as low as 4 to 6%
[11].
In 2004, faced with widespread parasite resistance,
Uganda has changed the antimalarial drug policy for
uncomplicated malaria to artemether-lumefantrine (AL),
(Coartem®). However, several concerns have been raised
with respect to the use of artemisinin derivative-based
combination therapy (ACT) in HBMF because of little
experience, in Africa, with ACTs outside clinical trials
[12,13]. The main concerns include: the feasibility and
acceptability of ACTs in HBMF, the adherence by caregiv-
ers and the dosing schemes too complex for CDDs, the
risk of increasing the spread of drug resistance, the high
cost of ACT, the potential for wastage and the uncertain-
ties in the supply of ACTs. However, a contrary view is that
ACT is the only available " bullet" in the face of increasing
drug resistance and that it would not be ethically and
morally right to continue using cheap drugs with sub-
optimal efficacy for poor people [14].
The prevalence of caregivers' perceived treatment failure
(CP-TF) in the formal and informal sectors, as well as in
HBMF, the factors associated with treatment outcome and
the corrective actions taken by caregivers in case of per-
ceived treatment failure were assessed in a rural Ugandan
setting.
Methodology
Study setting
The study was conducted in two counties (Kakuuto and
Kooki) in Rakai district, located approximately 200 kil-
ometers south of the capital city, Kampala. Rakai district
has meso-endemic malaria and is composed of four coun-
ties which are predominantly rural (the majority of the
residents practice subsistence farming). According to the
2002 population census, the total population of Rakai
district was 470,365 of whom 20% were children less than
five years of age. The study counties were composed of 12
sub counties, 43 parishes and 273 villages. The imple-
mentation of HBMF commenced in 2002.
Study design
A community-based cross-sectional study was conducted
using quantitative and qualitative data collection tech-
niques.
Quantitative data collection
Consenting caregivers of children between two and 59
months of age, who reside in the study counties and had
a child with fever in the two weeks prior to the study were
interviewed. Caregivers of children who were on medica-
tion and those who could not provide the required infor-
mation or refused to consent were excluded. A two-stage
cluster sampling method was used in which the parish
level was taken as a cluster. At the first stage, a cumulative
list of the households in the study parishes was prepared
and used to select the parishes (clusters) by probability
proportional to size (PPS). For the selection of house-
holds, a local guide facilitated the location of a central
place in the parish, and the direction to follow in the
selection of households was determined by randomly
spinning a bottle. The first household with a child less
than five years old, in the direction pre-determined
through the bottle spin was selected and the immediate
next household with a child of the target age was repeti-
tively selected until 40 caregivers of children had been
selected in a parish. Data for several variables from the
caregivers' were collected including; socio-demographic
characteristics (age, sex, religion, place of residence, tribe/
ethnic group and the highest education level achieved). In
addition, child related data were also collected including:
the age, the relationship of the child to the caregiver and
the number of children less than five years old in the
household. Further, data on accessibility to health services
including; availability of the HBMF CDD in the parish,
distance to nearest formal government/NGO health facil-
ity and presence of a private clinic/drug shop in the village
were also collected. Treatment seeking for malaria/feverMalaria Journal 2006, 5:124 http://www.malariajournal.com/content/5/1/124
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episode or the health seeking behavior of the respondents
was assessed by obtaining information on the time lag
between onset of fever and seeking treatment; the source
of initial treatment; and the type and place of additional
treatment received. Adherence to treatment and other
drug related factors was assessed by collecting informa-
tion on the dose administered; the dosing duration and
whether the drugs were shared with another person.
Qualitative data collection
Twelve key informant interviews and four focus group dis-
cussions (FGDs) were conducted to provide explanatory
information. The key informants included CDDs, the staff
in charge of health facilities and district health manage-
ment team officials. The FGDs were grouped by area of
residence. A social scientist moderated the discussions
and one of the other investigators recorded the notes.
Sample size estimation
The sample size estimates were derived as suggested previ-
ously [15,16] based on the following assumptions; a tol-
erable sampling error of 5%, fever prevalence for children
aged less than five years old in HBMF intervention areas
of 47% [5]; and a design effect of two. The number of
respondents per cluster was set at 40 for convenience and
the required number of clusters was 19.5 (rounded off to
20). A pre-study sample size of 800 respondents was
derived to cater for non responses and missing data.
Data management and statistical analysis
Data were entered into EPIINFO 6.04 (CDC, Atlanta GA),
cleaned and analysed in SPSS 12.0 and Stata version 9.0
(Stata Corp, Texas USA). The prevalence of caregivers per-
ceived treatment failure was defined as the proportion of
children who were treated and failed to recover (subjec-
tively reported by the caregivers) out of the total number
treated. The factors associated with treatment failure were
determined by carrying out bi-variate and multivariate
analysis. For the bi-variate analysis, associations between
independent variables and the outcome variable (CP-TF)
were assessed. Continuous independent variables were
categorized and their association with the outcome varia-
ble was established using Chi-square tests or fishers exact
test (for tables where cell values were less than five). The
measure of association for categorical variables was the
odds ratios (OR) with their 95% confidence intervals and
P values less than 0.05 were considered significant. In the
multivariate analysis, statistically significant factors at bi-
variate analysis were chosen. Confounding and interac-
tion between the various factors was assessed using logis-
tic regression.
Qualitative data from the FGDs and KI interviews, con-
ducted in the local language (Luganda) were translated
and transcribed into English, coded and thereafter ana-
lysed and separated into the emerging themes.
Quality control
Carefully chosen research assistants were trained on how
to conduct interviews and to make good observations. The
research instruments were translated into the local lan-
guage (Luganda). To improve validity, the semi-structured
questionnaire was pre-tested before data collection. An
operation manual was prepared and regular meetings
with the research assistants were conducted. Completed
questionnaires were cross-checked in the field to ensure
completeness and proper recording of the data.
Ethical considerations
Ethical clearance to conduct the research was sought from
the Makerere University Clinical Epidemiology Unit, Fac-
ulty of Medicine Research and Ethics Committee, and the
Rakai District Local Government. A written informed con-
sent was sought from all the caregivers and permission to
be admitted into the village was sought from the village
local councils.
Results
Social demographic characteristics
A total of 798 caregivers (coverage = 99%) were inter-
viewed on the treatment actions taken in response to fever
episodes occurring in the children less than five years of
age in the two weeks prior to the study. The median age of
the caregivers was 29 (range: 15–87) years and the mean
age was 31 (SD = 10.33) years. The median age for the
children was 25 (range: 2–59) months and the mean age
was 27 (SD = 15.7) months. Females comprised 88%
(704/798) of the caregivers and approximately 40% (320/
798) of the caregivers had attained an educational level of
upper primary (Primary 5 to 7). Less than 2% (12/798) of
the respondents had achieved an education above second-
ary level. The majority of the caregivers (82%, 653/798)
were married and over 90% (724/798) were subsistence
farmers. The total number of household members varied
from 2 to16 (mean = 6 people/household) and the
number of children below five years of age in the house-
holds varied from 1 to 6 (mean = 2) years. Caregivers who
were mothers of the children were 79% (628/798), while
fathers were only 10% (77/798). Grandparents and other
relatives were caregivers for 8% (66/798) and 3% (27/
798) of the children respectively. Almost 75% (594/798)
of the children lived in households headed by fathers.
Grandparents and mothers headed 14% (108/798) and
9% (74/798) of the households respectively, while other
relatives headed 3% (22/798) of the households.
Access to Health Services
Over 95% (777/798) of the caregivers lived within a five
kilometer radius from a government or a private not-for-Malaria Journal 2006, 5:124 http://www.malariajournal.com/content/5/1/124
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profit (PNFP) health facility. The mean distance to the
nearest government or PNFP health facility was about two
kilometers. The PNFP/NGO health units that charge user
fees were the nearest formal health facilities for approxi-
mately 25% (201/798) of the caregivers. Where a CDD
existed, over 90% (503/552) of caregivers lived a kilom-
eter or less from them. Surprisingly, over 30% (246/798)
of the caregivers were not aware of the existence of an
active CDD for HBMF in their village. The leading source
of information on health (76%, 603/798) was the radio,
followed by health workers at 42% (335//798).
Child related factors
The most common symptoms accompanying fever
among the children in descending order were: diarrhea,
vomiting, cough, failure to feed, and headache (Figure 1).
Over two thirds (532/798) of the children had an immu-
nization card showing the immunization status, while
another 15% (118/798) of the children did not have a
card but reported that they had received the recom-
mended immunization. About 19% (148/798) of the
children had not received the recommended immuniza-
tion for their age.
Treatment seeking for a fever episode
Administration of HOMAPAK obtained from the CDD
was the most common first treatment action (Figure 2).
Surprisingly, caregivers with a higher education level
tended to use HBMF more (p = 0.009) (Table 1). Neither
the marital status nor occupation of the respondent was
associated with using HBMF as the first treatment action.
The factors associated with using HBMF/HOMAPAK were:
distance to health facility (p = 0.004); distance to the CDD
(p < 0.001); having health workers as a major source of
health information (p = 0.016) or politicians/local leaders
as a major source of health information (p = 0.035).
Caregivers' perceptions on effectiveness of HBMF
The caregivers who had an active CDD in their village
were asked to comment on their satisfaction with HBMF
in fever management and 64% of them reported that they
were satisfied with the strategy. Several reasons for their
satisfaction were cited including; free provision of drugs;
easy accessibility to the CDD who readily explain to the
caregivers. Among the caregivers who were not satisfied
with HBMF, the most common reason cited was using
HOMAPAK previously without recovery; lack of confi-
dence in a non-medical person prescribing the treatment;
occurrence of stock-outs; and long distance from the
CDD.
Prevalence of treatment failure according to source of 
treatment
The overall prevalence of treatment failure was 38% (95%
CI: 34.1–42.7). Of the 281 children treated under HBMF
as the first treatment action for fever, 23% (95% CI: 18.0–
28.1) did not recover. However, among children treated
in government and NGO health facilities the prevalence
of treatment failure was 15% (95% CI: 9.6–21.8), while in
the private for profit sources (private clinics and drug
shops) the prevalence of treatment failure was 45% (95%
CI 39.3 – 51.2) (Table 2). The presence of vomiting, fail-
ure to feed, convulsions, extreme weakness and difficulty
in breathing were all associated with a higher likelihood
of perceived treatment failure (Table 3). The odds of treat-
ment failures were four times higher among children who
started treatment on the second day after the commence-
ment of symptoms compared to those who started treat-
ment within 24 hours of recognizing the symptoms.
Further, the odds of failure increased to over nine times
more among those who started treatment after 72 hours
(Table 4). There was an increased CP-TF (OR = 2.28, 95%
CI 1.30 – 4.02) among children who had been ill within
a month of the last episode of fever. Those who took med-
ication for only one day were three and a half times more
Caregivers' perceived treatment failure, according to first  action taken for children with fever Figure 2
Caregivers' perceived treatment failure, according to first 
action taken for children with fever.
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likely to experience treatment failure than those who com-
pleted treatment in the recommended duration, while
those who terminated treatment on second day had a
more than four-fold increase in CP-TF compared to those
who completed treatment (Table 4).
In a multivariate analysis, the factors independently asso-
ciated with a lower treatment failure under HBMF were:
timeliness from onset of symptoms to commencement of
treatment (OR = 0.10, 95% CI: 0.04–0.26) and comple-
tion of recommended treatment duration (OR = 0.3, 95%
CI: 0.13–0.69). The factors that increased CP-TF included:
vomiting (OR = 5.02, 95% CI: 2.31–10.92), convulsions
(OR = 10.51 95% CI: 4.46–24.77) and history of illness
within a month prior to the onset of the fever episode
treated under HBMF (OR = 2.46, 95% CI: 1.18–5.13)
(Table 5).
Of the 281 children treated under HBMF, 77.2% (217/
281) did not need to seek further treatment because they
had fully recovered, 11% (31/281) of them sought further
treatment from government or NGO health facility while
7% (20/281) went to private clinics. In less than 1% (2/
281), the caregivers used HOMAPAK again after the chil-
dren had failed to improve. Considering only those who
did not improve under HBMF as the first treatment, 48%
(31/64) sought additional care from the government or
NGO health facilities, while 31% (20/64) went to private
clinics (Table 6).
Qualitative assessments
Uptake of HBMF
The key informants and focus group discussions demon-
strated that the most commonly used source of treatment
for fever in the study area was HBMF. The following state-
ments describe some of the experiences:
"It is now easy... when a child gets fever you go to the drug dis-
tributor. It is a big relief... you don't need to have money and
the distributors are near to our homes (FGD, Lwanda Parish)"
Table 1: Demographic characteristics of 798 caregivers by first treatment action taken, Rakai Uganda, 2006
Total No Treatment% Use Herbs% Bought medicine% Health Centre/Hosp (Govt/NGO)% Private clinic% HBMF%
Education level
Never been to School 138 0.0 10.1 17.4 26.1 21.7 24.6
Primary 226 1.5 11.0 13.4 17.4 20.3 36.4
Post primary 320 0.0 4.4 19.3 4.0 20.2 42.1
Religion
Catholic 439 1.4 11.4 14.4 17.5 16.4 39.0
Protestants 201 0.5 8.0 14.4 20.4 27.9 28.9
Moslems 93 0.0 5.4 12.9 21.5 21.5 38.7
Other Christians 35 2.9 14.3 22.9 14.3 20.0 25.7
Others 30 0.0 10.0 23.3 13.3 30.0 23.3
Occupation
Peasant Farmer 724 0.8 10.4 14.4 19.2 20.4 34.8
Private Business 39 2.6 7.7 17.9 7.7 23.1 41.0
Civil Servant 17 0.0 5.9 11.8 23.5 11.8 47.1
Others 4 5.6 0.0 33.3 5.6 27.8 27.8
Marital Status
Married/living with spouse 653 0.8 9.6 14.7 19.6 21.4 33.8
Widowed 54 0.0 9.3 7.4 16.7 20.4 46.3
Divorced/Separated 45 2.2 13.3 22.2 11.1 15.6 35.6
Single/Never married 46 4.3 10.9 19.6 10.9 13.0 41.3
Table 2: Caregivers' perceived treatment failure by first treatment action, Rakai District, Uganda, 2006
Treatment Action N CP-TF% (n) 95% CI
Health Centre/Hosp (Government/NGO) 147 15.0 (22) 9.6 – 21.8
HBMF 281 22.8 (64) 18.0 – 28.1
Private clinic 164 38.4 (63) 30.9 – 46.3
Drug shop 119 54.6 (65) 45.2 – 63.8
Use Herbs 79 55.7 (44) 44.1 – 66.9
Overall 798 32.8 (262) 29.6 – 36.2Malaria Journal 2006, 5:124 http://www.malariajournal.com/content/5/1/124
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Key informants attributed the uptake of HBMF to high
sensitization of the communities about the strategy,
which they reported had helped to reduce congestion in
health facilities.
"You can't imagine how many children we used to attend to...
nowadays we mainly get severe cases. If children could be
started on treatment early, even the severe cases would be very
few". (Male Key Informant, health unit in-charge)
Easy access to drugs at all times of the day and from peo-
ple well known to the community was reported to be a big
attraction to the HBMF strategy.
"I grew up in this village... everybody knows me, that is why I
was selected to be a drug distributor. People like this treatment
because it works... we were taught to serve our people and we
try to do our best. That is why they have confidence in me
because when the illness is severe I refer them to the Health
Centre unlike the traditional healers (Female Key Informant,
Community Drug Distributor).
Reduced effectiveness of the HBMF
Some focus groups, however, indicated that the HBMF
program is no longer as active as before. "When this pro-
gram started everything was ok... these days you can't be sure
that the drugs will be there, therefore you resort to private clin-
ics which are nearer than the health centre and they always
have drugs (FGD, Kakuuto parish). In addition, there was a
perception of increasing treatment failure among children
treated under HBMF from both key informants and focus
groups.
"What we are talking about is chloroquine and Fansidar (sul-
phadoxine/pyrimethamine)... we know their fate and that is
why the government is changing the anti-malarial policy. Sur-
prisingly we still get many children who improve on
HOMAPAK although the number of those who fail to improve
appears to be on the increase" (Key informant, health unit in-
charge).
The focus groups also reported a declining effectiveness of
HBMF strategy. "May be when you use these drugs for long
they get weak... some fevers are too strong for these oral drugs...
that is why sometimes children fail to improve. We have also
discovered that when a child takes HOMAPAK without Pana-
dol (Paracetamol), the chances of improving are few" (FGD,
Lwensinga parish).
Table 4: Perceived treatment failure, time lag to receiving treatment after symptoms onset and adherence to duration of treatment 
among under-five children treated under HBMF, Rakai District, Uganda 2006
Period to seeking treatment after onset of symptoms N = 281 n (%) CP-TF% (n) OR (95% CI) p-value
Same day (within 24 hours) 162 (57.7) 10.5 (17) Reference
Second day 79 (28.1) 32.9 (26) 4.18 (2.10–8.32) 0.000
Three or more days 40 (14.2) 52.5 (21) 9.43 (4.24–20.95) 0.000
Duration of taking HOMAPAK
Three days and more 235 (83.6) 17.9 (42) Reference
One day 7 (2.5) 42.9 (3) 3.45 (0.74–5.98) 0.094
Two days 38 (13.5) 50.0 (19) 4.60 (2.24–9.42) 0.000
Table 3: Caregivers' perceived treatment failure and reported symptoms among 281 under-five year old children treated under 
HBMF, Rakai District, Uganda, 2006
Symptom N* CP-TF% (n) OR (95% CI) P-value
Failure to eat, drink or Breast feed 85 14.1 (12) 0.46 (0.23–0.91) 0.02
Headache 42 19.0 (8) 0.77 (0.33–1.76) 0.5
Diarrhea 129 20.9 (27) 0.82 (0.47–1.46) 0.5
Cough 136 25.0 (34) 1.29 (0.73–2.23) 0.4
Extreme weakness 28 39.3 (11) 2.44 (1.08–5.53) 0.03
Difficult breathing 20 45.0 (9) 3.06 (1.21–7.77) 0.01
Vomiting 124 33.9 (42) 3.14 (1.75–5.64) 0.000
Convulsions 51 58.8 (30) 8.24 (4.23–16.0) 0.000
*Total numbers are more than 281 because most children had multiple symptomsMalaria Journal 2006, 5:124 http://www.malariajournal.com/content/5/1/124
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Sustainability
There is a perception that in future the programme may
not be sustainable unless efforts are taken to improve the
incentive scheme for CDDs.
" The government provides the drugs and trains the CDD... it
remains a challenge to determine how much more the govern-
ment can add to facilitate the program. Our hope is that com-
munity members should assist the government to facilitate the
CDD. (Key Informant, CDD).
We bear a lot of burden for this program... we collect the drugs
from health centres, sometimes we wake up at night to give the
treatment, we sometimes provide transport for referring severely
ill children and we incur a lot more costs, with no refund from
government. Some people think we are paid, so they put pres-
sure on us. I am about to give up if things remain like this
(Female Key Informant, CDD).
The focus groups also demonstrated that although the
program is presently functional, its future is not clear.
The CDDs try... but I don't think they will go on for ever with-
out some form of facilitation. Even in our tradition, herbalists
get some payment (ekikuba nsiko), how do you expect them
(CDD) to serve us well without any payment? (FGD, Kakuuto)
Discussion
A client-focused approach was used to assess treatment
outcome for different sources of fever treatment including
HBMF and has provided seminal and important informa-
tion to improve HBMF implementation in Uganda and in
other malaria endemic countries. The caregivers' per-
ceived treatment failure under HBMF was rather high.
Nevertheless, the treatment outcome under HBMF was
better than that for private clinics and drug shops or herb-
alists, suggesting that HBMF still offers better treatment
outcomes compared to alternative informal treatment
actions accessible to rural communities. At the time of the
present study, CQ plus SP was the first line regimen in the
formal health facilities and in HBMF. Therefore, a possi-
ble explanation for the high perceived treatment failure in
HBMF is likely to be the high resistance to CQ plus SP
which eventually led to a change of the anti-malarial treat-
ment policy [6-10]. This study from a caregivers' perspec-
tive, therefore, supports earlier evidence from clinical
trials that the present regimen (CQ+SP) in the Ugandan
HBMF has sub-optimal treatment efficacy.
Home-based management of fever was the major treat-
ment action taken by caregivers in response to fever in
children aged less than five years. Considering that only
35% and 18% of the children were treated under HBMF
and at government/NGO health facilities respectively, the
formal health care system in Uganda only reaches 54% of
the children that require prompt and appropriate treat-
ment, an estimate still below the 60% Abuja target [18]. In
addition, the high prevalence of perceived treatment fail-
ure (38%–56%) in the alternative sources of treatment
action necessitates a paradigm shift in the approaches
Table 6: Treatment actions taken following perceived treatment failure among 281 under-five children who used HBMF as the first 
treatment action, Rakai District, 2006
Treatment Action N = 281 n (%) 95% CI
Required no more treatment 217 (77.2) 71.9–82.0
No treatment 3 (1.1) 0.2–3.1
Use herbs 3 (1.1) 0.2–3.1
Traditional healer 2 (0.7) 0.1–2.5
Bought medicine 3 (1.1) 0.2–3.1
Health centre/Hosp government/NGO) 31 (11.0) 7.6–15.3
Private clinic 20 (7.1) 4.4–10.8
HBMF 2 (0.7) 0.1–2.5
Table 5: Factors independently associated with perceived treatment failure among 281 under-five children treated under HBMF, Rakai 
District, 2006
Factor N = 281 CP-TF n (%) Adjusted OR 95% CI)
Treatment within 24 Hrs 162 10.5 (17) 0.10 (0.04–0.26)
Adherence to recommended duration of treatment 235 17.9 42 0.30 (0.13–0.69)
Treatment within 25–48 hours 79 32.9 (26) 0.32 (0.12–0.83)
Ill in the previous month 106 32.1 (34) 2.46 (1.18–5.13)
Vomiting 124 33.9 (42) 5.02 (2.31–10.92)
Convulsions 51 58.8 (30) 10.51 (4.46–24.77)Malaria Journal 2006, 5:124 http://www.malariajournal.com/content/5/1/124
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aiming at improving treatment outcome. Countries such
as Uganda have to increase the access to formal health
care or HBMF because these two sources have the lowest
perceived treatment failure (15%–23%). However, inno-
vative ways are needed to improve treatment outcome in
the non premium private sector. In Kenya, training shop-
keepers improved correct treatment with chloroquine to
approximately 65% [19]. More recently, in Uganda better
performance was observed after negotiating with the
informal drug shops, [20] and in Tanzania accredited
drug-dispensing outlets (ADDOs) that supply antimalar-
ial medicines recommended by the national policy per-
form better than those that are not accredited. Presently,
the international community is lobbying for globally sub-
sidized ACTs. However, there is a need to go beyond sub-
sidies, because ready availability of ACTs without the
supporting activities such as training, guidelines, job aids,
group processes, regular supervision and monitoring will
not achieve optimal results [21,22].
Presence of vomiting, convulsions and illness in the pre-
vious month were all independently associated with a
high perceived treatment failure, suggesting that the
CDDs need to look for these signs and symptoms and
promptly refer those children they can not manage. In
Ghana, community based agents (CBAs) who were pro-
vided limited skills to establish through further enquiry
and observation the overt signs that could indicate severe
disease performed better than those who had not [23].
As expected, children who were started on treatment after
24 hours of fever onset were 10 times more likely to expe-
rience treatment failure compared to those who started
treatment within 24 hours of fever onset. Similarly, those
taking HOMAPAK over the recommended three days
duration were three-times less likely to experience treat-
ment failure. These findings highlight the negative impact
of non-compliance with national and international guide-
lines and suggest that the HBMF strategy needs a sustained
communication strategy that addresses client and pro-
vider adherence to guidelines.
Diarrhea, vomiting, cough, failure to feed, convulsions
and headache were the most common symptoms accom-
panying fever among the children. However, many symp-
toms for uncomplicated malaria overlap with those of
severe malaria and acute respiratory infections (ARI)
[24,25]. HBMF is intended for uncomplicated malaria,
but in some cases severe malaria and patients with ARI are
sometimes treated with HOMAPAK. This is the most likely
explanation for the lower perceived treatment failure in
the formal health care compared to HBMF because other
causes of fever could have been investigated in the formal
health care, improving the treatment outcome.
There are some limitations in this study. First, the caregiv-
ers could have given information they thought was desir-
able and acceptable or they could have exaggerated
information in anticipation of assistance from the
researchers. If this was the case, then the perceived treat-
ment failure that was observed is likely to be biased on the
favorable side, implying that our conclusions are really
modest. Second, recall bias could have occurred. Mini-
mizing recall bias was attempted through restricting inter-
views to the fever episodes that occurred two weeks
preceding the study. Third, measurement of time from
fever onset to treatment action is likely to be inaccurate
because in rural areas people often tell time based on the
position of the sun or from the occurrence of major
events. Harmonizing the time reported by caregivers and
the actual time to treatment action may have been biased
leading to over or under estimation of time to treatment
action. However, categorizing time into days reduces such
inaccuracies. Finally, there could have been differences
between research assistants in the measurement of the dif-
ferent study items (Inter-observer variability). Regular
meetings between the research assistants and the investi-
gators were held in an effort to reduce inter observer
errors.
The caregivers perceived treatment failure in HBMF was
almost 25%, suggesting that the present regimen has sub-
optimal treatment efficacy. Implementation studies are
urgently needed for the rational deployment of a more
effective regimen in HBMF. In addition, Uganda should
develop an information, education and communication
(IEC) strategy that will improve adherence to HBMF
guidelines. Further, there is a need to setup easy-to-reach
and well facilitated formal health units in areas served by
HBMF to quickly manage severe cases so as to limit the
temptation to solely rely on HBMF to treat severely ill chil-
dren. Finally, to ensure continuity of HBMF, especially in
rural areas where the available non-formal alternatives for
fever management are not as effective as HBMF, sustaina-
ble ways of facilitating the CDDs should be explored.
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